Rock Springs Capital Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-165,300
| Closed | -$213K | – | 166 |
|
|
2017
Q4 | $213K | Hold |
165,300
| – | – | 0.01% | 143 |
|
|
2017
Q3 | $350K | Hold |
165,300
| – | – | 0.02% | 145 |
|
|
2017
Q2 | $479K | Hold |
165,300
| – | – | 0.02% | 142 |
|
|
2017
Q1 | $569K | Hold |
165,300
| – | – | 0.03% | 137 |
|
|
2016
Q4 | $288K | Hold |
165,300
| – | – | 0.02% | 132 |
|
|
2016
Q3 | $549K | Hold |
165,300
| – | – | 0.03% | 135 |
|
|
2016
Q2 | $711K | Hold |
165,300
| – | – | 0.05% | 134 |
|
|
2016
Q1 | $930K | Buy |
165,300
+300
| +0.2% | +$1.69K | 0.08% | 122 |
|
|
2015
Q4 | $2.84M | Hold |
165,000
| – | – | 0.22% | 103 |
|
|
2015
Q3 | $3.48M | Buy |
165,000
+10,000
| +6% | +$211K | 0.28% | 101 |
|
|
2015
Q2 | $7.67M | Hold |
155,000
| – | – | 0.56% | 66 |
|
|
2015
Q1 | $12.1M | Sell |
155,000
-13,500
| -8% | -$1.06M | 1.14% | 28 |
|
|
2014
Q4 | $10.2M | Buy |
168,500
+43,500
| +35% | +$2.64M | 1.19% | 25 |
|
|
2014
Q3 | $5.33M | Buy |
125,000
+34,500
| +38% | +$1.47M | 0.82% | 38 |
|
|
2014
Q2 | $5.59M | Buy |
90,500
+7,500
| +9% | +$464K | 1% | 32 |
|
|
2014
Q1 | $5.4M | Buy |
83,000
+30,500
| +58% | +$1.98M | 1.24% | 25 |
|
|
2013
Q4 | $2.96M | Buy |
+52,500
| New | +$2.96M | 1.06% | 27 |
|